Editas Medicine (EDIT) Minority Interest (2015)
Editas Medicine (EDIT) reported Minority Interest of $59.0 million for Q4 2015.
Editas Medicine (EDIT) has 1 years of Minority Interest data on file, last reported at $59.0 million in Q4 2015.
- Quarterly Minority Interest changed N/A year-over-year to $59.0 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $59.0 million (changed N/A YoY) and the FY2015 annual result came in at $59.0 million, up 184.17% from the prior year.
- Minority Interest steadied at $59.0 million in Q4 2015 per EDIT's latest filing.
- Across five years, Minority Interest topped out at $59.0 million in Q4 2015 and bottomed at $59.0 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 59.03 Mn |